Rephonic
Artwork for IJGC conversations

IJGC conversations

ijgcgroup
Ovarian Cancer
Endometrial Cancer
Cervical Cancer
Uterine Leiomyosarcoma
Neoadjuvant Chemotherapy
Oral Mucositis
Gynecologic Oncology
Immunotherapy
Cancer In Pregnancy
Circulating Tumor DNA
Checkpoint Inhibitors In Endometrial Cancer
Antibody Drug Conjugates (adcs) Gynecologic Cancers
Pregnancy-Associated Gynecologic Cancers
Sentinel Lymph Node Biopsy
Aggressive Histology Endometrial Cancer
Sassituzumab Govitecan
Low-Grade Serous Ovarian Cancer
NCCN Guidelines
Molecular Integrated Risk Profile
Minimally Invasive Surgery

The International Journal of Gynecological Cancer (IJGC) conversations is a podcast that brings you the latest insights into gynecologic malignancies. Tune in to engaging conversations with leading experts as they explore innovative and timely topics shaping the field. Hosted by the Editor-in-Chief Dr. Pedro Ramirez and special guests, each episode offers a dynamic and educational experience desig... more

PublishesWeeklyEpisodes80Founded2 years ago
Number of ListenersCategories
MedicineHealth & Fitness

Listen to this Podcast

Artwork for IJGC conversations

Latest Episodes

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Gabriel Levin to discuss Salpingo-oophorectomy at Radical Hysterectomy for Cervical Adenocarcinoma.

Dr. Gabriel Levin is a gynecologic oncologist and clinical resea... more

YouTube

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Giuseppe Caruso to discuss Lymphadenectomy in Early-Stage Ovarian Cancer.

Dr. Giuseppe Caruso, MD PhD works as a consultant gynecologic oncologist at the Europe... more

YouTube

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Robert Coleman to discuss Vaccine Therapy in Ovarian Cancer: Role of Gemogenovatucel-T.

Dr. Coleman completed his Obstetrics & Gynecology residency at Northwest... more

YouTube

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Brian M. Slomovitz and David M. Gershenson to discuss Ribociclib Plus Letrozole in Recurrent Low-Grade Serous Carcinoma of the Ovary: GOG 3026.

Dr. Slomovitz i... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Listen to Gynecologic Oncology
Listen to Gynecologic OncologyGynecologic Oncology
Ready, Set, GYO!
Ready, Set, GYO!Ready, Set, GYO: An educational gynecologic oncology podcast
ASCO Daily News
ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)
The Daily
The DailyThe New York Times

Recent Guests

Rob Coleman
Researcher specializing in tumor-specific, patient-derived vaccines and ovarian cancer immunotherapy
Episode: Vaccine Therapy in Ovarian Cancer: Role of Gemogenovatucel-T
Dr. David Gershenson
Expert in gynecologic oncology, University of Texas MD Anderson Cancer Center
MD Anderson Cancer Center
Episode: Ribociclib Plus Letrozole in Recurrent Low-Grade Serous Carcinoma of the Ovary: GOG 3026
Vanna Zanagnolo
Gynecologic oncologist at European Institute of Oncology, Milan
European Institute of Oncology
Episode: Single-Port Robotic Surgery: Safety and Feasibility
Lucia Ribero
Gynecologic oncologist at European Institute of Oncology, Milan
European Institute of Oncology
Episode: Single-Port Robotic Surgery: Safety and Feasibility
Vivek Podder
Research Fellow, Division of Gynecological Oncology, Mount Sinai Medical Center
Mount Sinai Medical Center, Miami Beach, FL
Episode: GLP1-Receptor Agonists in Endometrial Cancer
Brian Slomovitz
Professor, Division of Gynecologic Oncology, Mount Sinai Medical Center
Mount Sinai Medical Center
Episode: GLP1-Receptor Agonists in Endometrial Cancer
Mario Leitao
US Board Certified Gynecology Oncologist; Director of Gynecology Oncology Fellowship Program at MSK; ESGO-accredited training leader
Memorial Sloan Kettering Cancer Center
Episode: Mentor's Podcast: Mario M. Leitao, Jr.
Dr. René Pareja
Associate Editor
Instituto Nacional de Cancerología, Bogota; Clinica Astorga, Medellín
Episode: Topical Treatments for HPV: Fact or Flawed Science
Dr. Anne-Sophie van den Heerik
Lead investigator discussing PORTEC-4A results
Unknown (Lancet Oncology Radiotherapy/Oncology references)
Episode: Molecular Profile-Based Adjuvant Treatment Endometrial Cancer: PORTEC-4a

Host

Dr. Pedro Ramirez
Editor-in-Chief of IJGC Conversations and host of the podcast

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

IJGC EiC Summer Podcasts: ctDNA in Endometrial Cancer with Ilaria Capasso, Camilla Nero, and Evelyn A. Reynolds
Q: Can ctDNA replace tissue biopsy for diagnosis or initial classification in endometrial cancer?
Currently no; tissue biopsy remains essential for primary diagnosis, though ctDNA could play a complementary role in surveillance and selecting high-risk patients, with future potential for tumor-informed approaches.
IJGC EiC Summer Podcasts: ctDNA in Endometrial Cancer with Ilaria Capasso, Camilla Nero, and Evelyn A. Reynolds
Q: What is the timing difference between ctDNA positivity and radiologic appearance of disease, particularly for recurrence?
ctDNA can precede radiologic relapse by several months in various cancers, with lead times ranging from several months in reports across breast and gynecologic cancers, to a similar range in gynecologic malignancies, though exact numbers vary by study.
PEACOCC Trial: Pembrolizumab in Clear Cell Cancer with Rebecca Kristeleit
Q: Considering ongoing trials, can we begin to favor one immunotherapy regimen over another for clear cell gynecologic cancers?
Current data suggest that single-agent immunotherapy shows activity and is a reasonable backbone; combination strategies with anti-angiogenics or other agents may improve outcomes, but definitive superiority awaits results from randomized trials like DOV and others.
PEACOCC Trial: Pembrolizumab in Clear Cell Cancer with Rebecca Kristeleit
Q: Given that biomarkers like MMR deficiency and PD-L1 did not clearly predict response, what alternative molecular features would you include in future studies?
Emphasize tumor mutational burden and tumor-infiltrating lymphocytes, plus spatial immune architecture; plan to analyze TMB with translational work and consider microbiome-related factors that may influence immune responses.
PEACOCC Trial: Pembrolizumab in Clear Cell Cancer with Rebecca Kristeleit
Q: How many participants in the trial had pure clear cell histology versus mixed histology, and did outcomes differ between these subgroups?
Histopathology was stringently confirmed by specialist gyneho-histopathologists with a threshold of at least 50% clear cell morphology; while precise subgroup outcomes were not broken out in the primary dataset, careful review suggests no major divergence between pure and mixed clear cell histology within the data examined.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About IJGC conversations

What is IJGC conversations about and what kind of topics does it cover?

A collection of in-depth interviews and panel discussions centered on gynecologic cancers, with heavy emphasis on translational and clinical practice in ovarian, endometrial, and cervical malignancies. Topics span innovative therapies (biomarker-driven vaccines, CDK4/6 inhibitors, immunotherapy combinations), surgical advances (single-port robotic techniques, fertility-preserving approaches, sentinel node strategies), trial design and interpretation (PORTEC-4a, B96, real-world practice patterns), and de-escalation of treatment to reduce morbidity without compromising outcomes. Notable is a consistent focus on biomarkers, molecular profiling, and how translational research translates into patient care, guidelines, and trial design. The forma... more

Where can I find podcast stats for IJGC conversations?

Rephonic provides a wide range of podcast stats for IJGC conversations. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to IJGC conversations and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does IJGC conversations get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for IJGC conversations, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for IJGC conversations?

Rephonic provides comprehensive predictive audience data for IJGC conversations, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does IJGC conversations have?

To see how many followers or subscribers IJGC conversations has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to IJGC conversations?

These podcasts share a similar audience with IJGC conversations:

1. Listen to Gynecologic Oncology
2. Ready, Set, GYO!
3. ASCO Daily News
4. Up First from NPR
5. The Daily

How many episodes of IJGC conversations are there?

IJGC conversations launched 2 years ago and published 80 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact IJGC conversations?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for IJGC conversations?

Rephonic pulls ratings and reviews for IJGC conversations from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for IJGC conversations?

Rephonic provides full transcripts for episodes of IJGC conversations. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on IJGC conversations?

Recent guests on IJGC conversations include:

1. Rob Coleman
2. Dr. David Gershenson
3. Vanna Zanagnolo
4. Lucia Ribero
5. Vivek Podder
6. Brian Slomovitz
7. Mario Leitao
8. Dr. René Pareja

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days